Related Experiment Video
Updated: Aug 2, 2026

High-resolution Time-lapse Imaging and Automated Analysis of Microtubule Dynamics in Living Human Umbilical Vein Endothelial Cells
Published on: August 13, 2016
Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II
Q Zeng1, D Lagunoff, R Masaracchia
1Department of Pathology, St Louis University School of Medicine St Louis, Missouri 63104-1028, USA.
Abstract:
The p21-activated kinase (PAK) family includes several enzyme isoforms regulated by the GTPases Rac1 and Cdc42. PAK1, found in brain, muscle and spleen, has been implicated in triggering cytoskeletal rearrangements such as the dissolution of stress fibers and reorganization of focal complexes. The role of the more widely distributed PAK2 in controlling the cytoskeleton has been less well studied. Previous work has demonstrated that PAK2 can monophosphorylate the myosin II regulatory light chain and induce retraction of permeabilized endothelial cells. In this report we characterize PAK2's morphological and biochemical effect on intact endothelial cells utilizing microinjection of constitutively active PAK2. Under these conditions we observed a modification of the actin cytoskeleton with retraction of endothelial cell margins accompanied by an increase in monophosphorylation of myosin II. Selective inhibitors were used to analyze the mechanism of action of PAK2. Staurosporine, a direct inhibitor of PAK2, largely prevented the action of microinjected PAK2 in endothelial cells. Butanedione monoxime, a non-specific myosin ATPase inhibitor, also inhibited the effects of PAK2 implicating myosin in the changes in cytoskeletal reorganization. In contrast, KT5926, a specific inhibitor of myosin light chain kinase was ineffective in preventing the changes in morphology and the actin cytoskeleton. The additional finding that endogenous PAK2 associates with myosin II is consistent with the proposal that cell retraction and cytoskeletal rearrangements induced by microinjected PAK2 depend on the direct activation of myosin II by PAK2 monophosphorylation of the regulatory light chain.
Insights
p21-activated kinase 2 (PAK2) triggers endothelial cell retraction and actin cytoskeleton changes by directly activating myosin II. This involves monophosphorylation of the myosin II regulatory light chain, confirmed by inhibitor studies.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The p21-activated kinase (PAK) family, including PAK1 and PAK2, are key regulators of the actin cytoskeleton, influenced by GTPases Rac1 and Cdc42.
- While PAK1's role in cytoskeletal dynamics is established, PAK2's function in intact cells, particularly its interaction with myosin II, remains less understood.
- Previous studies indicated PAK2's ability to monophosphorylate myosin II regulatory light chain and induce retraction in permeabilized endothelial cells.
Purpose of the Study:
- To investigate the morphological and biochemical effects of constitutively active PAK2 on intact endothelial cells.
- To elucidate the mechanism by which PAK2 induces cytoskeletal rearrangements and cell retraction.
- To determine the specific role of myosin II activation in PAK2-mediated cellular changes.
Main Methods:
- Microinjection of constitutively active PAK2 into intact endothelial cells.
- Utilizing selective inhibitors: Staurosporine (PAK2 inhibitor), Butanedione monoxime (myosin ATPase inhibitor), and KT5926 (myosin light chain kinase inhibitor).
- Analysis of actin cytoskeleton modifications, cell margin retraction, and myosin II regulatory light chain monophosphorylation.
- Investigating the association between endogenous PAK2 and myosin II.
Main Results:
- Microinjection of active PAK2 induced endothelial cell retraction and actin cytoskeleton reorganization.
- A significant increase in myosin II regulatory light chain monophosphorylation was observed following PAK2 activation.
- PAK2 inhibition by Staurosporine blocked PAK2-induced effects, while myosin ATPase inhibition by Butanedione monoxime also prevented these changes.
- Myosin light chain kinase inhibition by KT5926 did not affect PAK2-induced cytoskeletal alterations.
- Endogenous PAK2 was found to associate with myosin II.
Conclusions:
- PAK2 directly activates myosin II through monophosphorylation of its regulatory light chain, leading to endothelial cell retraction.
- The observed cytoskeletal rearrangements are dependent on myosin II activity, but not mediated by myosin light chain kinase.
- These findings highlight a direct mechanism for PAK2 in regulating cell morphology and motility via myosin II activation.
More Related Videos
09:20The Assembly and Application of 'Shear Rings': A Novel Endothelial Model for Orbital, Unidirectional and Periodic Fluid Flow and Shear Stress
Published on: October 31, 2016
12:35Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
Published on: April 14, 2023
Related Concept Videos
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Cancer Cell Migration through Invadopodia
Mechanism of Lamellipodia Formation
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...
Intracellular Signaling Affects Focal Adhesions
Some...